Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Influence of amesergide treatment on the dextromethorphan test.

× No keyword cloud information.

7 in total

1. Clinical significance of the sparteine/debrisoquine oxidation polymorphism.

Authors: K Brøsen; L F Gram
Journal: Eur J Clin Pharmacol Date: 1989 Impact factor: 2.953

2. Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes.

Authors: C von Bahr; E Spina; C Birgersson; O Ericsson; M Göransson; T Henthorn; F Sjöqvist
Journal: Biochem Pharmacol Date: 1985-07-15 Impact factor: 5.858

3. Dextromethorphan and mephenytoin phenotyping of patients treated with thioridazine or amitriptyline.

Authors: P Baumann; J W Meyer; M Amey; D Baettig; C Bryois; M Jonzier-Perey; L Koeb; C Monney; B Woggon
Journal: Ther Drug Monit Date: 1992-02 Impact factor: 3.681

4. Polymorphic dextromethorphan metabolism: co-segregation of oxidative O-demethylation with debrisoquin hydroxylation.

Authors: B Schmid; J Bircher; R Preisig; A Küpfer
Journal: Clin Pharmacol Ther Date: 1985-12 Impact factor: 6.875

5. The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.

Authors: H K Crewe; M S Lennard; G T Tucker; F R Woods; R E Haddock
Journal: Br J Clin Pharmacol Date: 1992-09 Impact factor: 4.335

6. Preclinical studies on LY237733, a potent and selective serotonergic antagonist.

Authors: M M Foreman; R W Fuller; D L Nelson; D O Calligaro; K D Kurz; J W Misner; W L Garbrecht; C J Parli
Journal: J Pharmacol Exp Ther Date: 1992-01 Impact factor: 4.030

7. Polymorphic hydroxylation of Debrisoquine in man.

Authors: A Mahgoub; J R Idle; L G Dring; R Lancaster; R L Smith
Journal: Lancet Date: 1977-09-17 Impact factor: 79.321

7 in total